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Laboratory of Immunogenetics (MCP-1) in monocytes. TREM-1 activation also induces
Ca2 influx and tyrosine phosphorylation of several pro-National Institute of Allergy and
Infectious Diseases teins, particularly mitogen activated protein kinases
ERK1 and ERK2. Expression of TREM-1 is upregulatedNational Institutes of Health
12441 Parklawn Drive in response to Toll-like receptor activation and is accom-
panied by an increased production of the proinflamma-Rockville, Maryland 20852
2 Department of Pathology and Immunology tory cytokines TNF- and GM-CSF, while production of
the anti-inflammatory cytokine IL-10 is inhibited, sug-Washington University School of Medicine
Box 8118 gesting a role for the receptor in acute inflammation
(Bleharski et al., 2003). Excessive release of TNF-, in-660 South Euclid Avenue
St. Louis, Missouri 63110 terleukin-1, and other proinflammatory cytokines and
chemokines in response to infections is believed to
cause sepsis syndrome-related multiple organ failure
(Beutler et al., 1985; Glauser et al., 1991; Nathan andSummary
Ding, 2001). Interestingly, priming neutrophils and
monocytes with lipopolysaccharide (LPS), lipoteichoicTriggering receptors expressed on myeloid cells (TREM)
acid, heat-inactivated Gram-positive bacteria, Gram-are a family of recently discovered receptors that play
negative bacteria, or fungi induces strong upregulationimportant roles in innate immune responses, such as
of TREM-1. In addition, TREM-1 was found on neutro-to activate inflammatory responses and to contribute
phils isolated from the peritoneal cavity of patients orto septic shock in response to microbial-mediated in-
mice with bacterial septic shock. In contrast, little or nofections. To date, two TREM receptors in human and
TREM-1 could be detected in nonmicrobial inflamma-several homologs in mice have been identified. We
tory lesions, such as psoriasis, ulcerative colitis, andreport the 2.6 A˚ resolution crystal structure of the ex-
vasculitis (Bouchon et al., 2001). Thus, TREM-1, withtracellular domain of human TREM-1. The overall fold
its synergistic activation during inflammation, may alsoof the receptor resembles that of a V-type immuno-
contribute to the excessive inflammatory response dur-globulin domain with differences primarily located in
ing septic shock (Cohen, 2001; Nathan and Ding, 2001).the N-terminal strand. TREM-1 forms a “head-to-tail”
Furthermore, mice treated with a murine TREM-1/IgG1-dimer with 4100 A˚2 interface area that is partially medi-
Fc fusion protein exhibited a partial protection againstated by a domain swapping between the first strands.
LPS-induced endotoxic shock, indicating the potentialThis mode of dimer formation is different from the
therapeutic significance of this type of treatment.“head-to-head” dimerization that existed in VHVL do-
Like many other activating receptors that lack signal-mains of antibodies or V domains of T cell receptors.
ing components in their cytoplasmic tails, TREM-1 andAs a result, the dimeric TREM-1 most likely contains
-2 associate with the immunoreceptor tyrosine-basedtwo distinct ligand binding sites.
activation motif (ITAM)-containing molecule DAP12
through a charged residue in their transmembrane re-
Introduction gions (Lanier et al., 1998). In contrast, TLT-1, -2, and -3
contain immunoreceptor tyrosine-based inhibitory mo-
Triggering receptors expressed on myeloid cells (TREM) tifs (ITIMs) in their cytoplasmic tails and thus may confer
are a family of recently discovered activating receptors inhibitory functions (Allcock et al., 2003).
that may play important roles in myeloid cell-mediated In general, TREMs show relatively low sequence iden-
inflammatory responses (Bouchon et al., 2000, 2001; tity (20%–30%) among them. The exceptions are human
Daws et al., 2001). The prototypic members of the family, and mouse TREM-1 and mouse TREM-1 and TREM-3
TREM-1 and TREM-2, were identified in humans on chro- which share 46% and 43% sequence identity, respec-
mosome 6 and are expressed on myeloid cells. More tively. Structurally, the extracellular regions of all TREMs
recently, three TREM-like transcripts, TLT-1, -2, and -3, consist of a single V-type immunoglobulin (Ig)-like do-
were found in the TREM cluster on human chromosome main (Ig-V) of about 120 amino acids in length, followed
6 (Allcock et al., 2003). In mice, five activating forms, by a neck region of about 70 amino acids. Despite in-
TREM-1 to TREM-5, and an inhibitory form, TLT-1, were tense efforts, the ligands of TREM receptors remain
found to reside on chromosome 17 (Chung et al., 2002; unknown. To better understand the function of this fam-
Washington et al., 2002). TREM-1 expression is found ily of receptors, we have determined the crystal structure
on monocytes and neutrophils and may contribute to of the extracellular Ig-V domain of human TREM-1 at
the maturation of stem cells to monocytes (Gingras et 2.6 A˚ resolution. Analysis of the TREM-1 structure and
al., 2002). Upon cross-linking, TREM-1 induces interleu- comparison to structures of other members of V-type
Ig fold illustrate a unique “head-to-tail” receptor subunit
association encompassing 4100 A˚2 interface area. This*Correspondence: psun@nih.gov
Structure
1528
Table 1. Data Collection, Phasing, and Refinement Statistics
Data Collection
Native Se (Remote) Se (Peak) Se (Edge) Au (Remote)a
Beamline SBC-CAT SER-CAT SER-CAT SER-CAT SER-CAT
Wavelength (A˚) 1.0376 0.9641 0.9790 0.9791 1.0246
Resolution limit (A˚) 2.6 3.2 3.2 3.2 2.6
Unique reflections 23897(2369)b 11567(724) 12178(899) 13193(1319) 21585(1225)
Redundancy 4.2(4.2) 6.3(3.5) 6.8(4.0) 6.9(4.7) 3.4(1.9)
Completeness (%) 98.6(97.7) 90.3(56.1) 94.1(70.2) 99.8(99.2) 90.8(51.8)
Rsym (%)c 8.6(44.0) 16.3(48.7) 15.2(42.1) 15.8(44.2) 10.1(32.6)
I/(I ) 23.5(4.2) 9.6(2.0) 12.2(2.7) 12.6(3.2) 14.1(1.9)
MAD Phasing SeMet (15.0–4.0 A˚)
Mean figure of merit 0.41
MIR Phasing (15.0–3.0 A˚) Se (Peak) Au (Remote)
Mean figure of merit 0.25
Phasing Powerd 1.07 1.05




No. protein atoms 3928
No. solvent atoms 229
Rcryst (%) 20.1(32.3)
Rfree (%)f 25.1(37.6)
Mean B factor (A˚2) 38
Wilson B factor (A˚2) 47
Rmsd bond lengths (A˚) 0.007
Rmsd bond angles () 1.67
a Data collected on KAu(CN)2-soaked crystal.
b Values in parentheses are for highest resolution shells: 2.6–2.7 A˚ (native), 3.1–3.2 A˚ (SeMet datasets), and 2.6–2.7 A˚ (KAu(CN)2 remote).
c Rsym  100 	 
|Ih  Ih |/
Ih, where Ih is the mean intensity of multiple measurements of symmetry equivalent reflections.
d Phasing power  rms(FH)/rms(E ), where FH is the calculated heavy-atom structure factor, and E is the phase-integrated lack of closure.
e Rcullis  
||FPH  FP|  FH|/
|FPH  FP|, where FP and FPH are observed structure factors for the native and the derivative, and FH is the calculated
heavy-atom structure factor.
f Rfree was calculated using test set of 5%.
dimer formation is mediated, in part, by a domain swap- Overall Structure
ping between the first strands of the monomers. The The overall structure of TREM-1 is similar to a typical
difference between the TREM-1 dimerization and the Ig-V domain, which consists of nine strands forming two
“head-to-head” dimerization mode observed for V do- antiparallel  sheets locked together by a conserved
mains of antibodies and T cell receptors may have impli- disulfide bond between strands B and F (Figure 1). The
cations to the function of TREM-1 receptor. first sheet is formed by the strands B-E-D-C″ and the
second one by the strands A-G-F-C-C. The four mono-
mers in each asymmetric unit form two tightly associ-Results and Discussion
ated dimers. Structural comparisons between TREM-1
and other members of Ig superfamily (IgSF) such as VHVLStructure Determination
domains of IgG1, VV domains of T cell receptor (TCR)The structure of the extracellular Ig-like domain of
(Figure 1C), VV TCR, CD8, and CTLA-4 result inTREM-1, amino acids 17–133, was determined to 2.6 A˚
1.5–2.0 A˚ rms deviations for 76–83 superimposed Cresolution by a combination of selenomethinone-based
atoms. TREM-1, however, deviates from a classical Ig-Vmultiwavelength anomalous dispersion (MAD) and a
domain in the conformation of the first  strand. In agold-derivative-based single isomorphous replacement
typical V-type Ig fold, the first strand breaks into two(SIR) methods to 2.6 A˚ resolution (Table 1). The crystals
shorter strands, A and A, where the strand A is hydrogenbelong to a monoclinic space group P21 with cell dimen-
bonded to strand B of one  sheet and the A, followingsions a  50.3, b  128.6, c  62.4 A˚, and   101.7
a typical “strand switch,” pairs with strand G of theand four molecules in each asymmetric unit. The refined
opposing  sheet. In the TREM-1 structure, strand A iscrystallographic and free R factors are 20.1% and
distal to the core of the protein to form a parallel  sheet25.1%, respectively. After refinement, the electron den-
with strand B of the other monomer (Figure 2A). As asity map was contiguous in all four molecules from resi-
result, strand A pairs first with the G of the other mono-due Glu 17 to Thr 133. The N-terminal Met 16 as well
mer and then with G of itself. Recently, the structureas Leu 134 and Glu 135, which are part of the C-terminal
tag, were also visible in the electron density map. of NK cell natural cytotoxicity receptor NKp44, from the
TREM-1 Crystal Structure
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Figure 1. Ribbon Drawing of the TREM-1 Monomer
(A) Front view. All secondary structure elements on TREM-1 are marked in accordance with the sequence alignment in Figure 4.
(B) Side view of TREM-1. Molecule is rotated about 90 compare to the front view.
(C) Structural comparison between TREM-1 and V domain of TCR. This figure and all subsequent ribbon drawings are prepared using the
program MOLSCRIPT (Kraulis, 1991), and RASTER3D (Merritt and Bacon, 1997).
same gene cluster as TREMs (Allcock et al., 2003), was C of the other extend the  sheet of each monomer
into a contiguous barrel-like structure. The buried surfacedetermined (Cantoni et al., 2003). NKp44 also displays
a V-type Ig fold with an rms deviation of 1.3 A˚ to TREM-1 area between the two TREM-1 monomers is 4100 A˚2,
about twice the 1500–1600 A˚2 that is buried by VHVLstructure. However, unlike other members of the family,
NKp44 contains a unique disulfide bond between C and antibody dimers or VV and VV of TCRs. The more
than 2-fold increase in the buried surface with respectC strands. TREM-1 structure also has Cys 69 in its C
strand but lacks a complementary cysteine in C strand. to antibody-like dimer is primarily due to the additional
interactions between the swapped A and A strands inAnother feature of NKp44 that is different from other
V-type Ig domains is the existence of a positively TREM-1 (Bennett et al., 1995; Rousseau et al., 2003; Liu
and Eisenberg, 2002). When the first 7 residues fromcharged grove on its surface formed by C-C and F-G
strands. In addition, NKp44 does not form a dimer in strand A of TREM-1, which are involved in domain swap-
ping, are removed, the buried surface area is reducedsolution and only a crystallographic dimer was observed
in the NKp44 structure. to about 2600 A˚2.
In addition to hydrogen bonds, the TREM-1 dimer is
also stabilized by salt bridges and hydrophobic interac-TREM-1 Dimer Formation
The extracellular Ig-V domain of TREM-1 exists as a tions. Specifically, there are two salt bridges between
the opposing molecules at the dimer interface: Asp 60dimer in solution as determined by size exclusion chro-
matography (data not shown). In the crystal, TREM-1 to Arg 72, and Glu 62 to His 123 (Figure 2B). Prominent
residues at the hydrophobic interface include Leu 18,forms a noncrystallographic symmetry (NCS)-related di-
mer with the concave surfaces of the G-F-C-C sheets Ala 20, Leu 24, Tyr 29, Val 39, Met 63, Pro 64, Tyr 116,
Met 124, Leu 125, Phe 126, and Ile 129 of both monomersof the two monomers facing each other (Figure 2A).
An array of hydrogen bonds formed between the edge (Figure 2C). The two TREM-1 dimers in each asymmetric
unit are related by a 2-fold noncrystallographic symme-strands, A, A, and C of one monomer and B, G, and
Structure
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Figure 2. TREM-1 Dimer Interfaces
(A) Stereoview of TREM-1 dimer. Secondary structure elements involved in the interactions between N termini painted green in one monomer
and yellow in another one.
(B) Detailed view of the hydrophobic core formed at the dimer interface by the N termini of TREM-1.
(C) Interactions between CC regions of the monomers.
(D) Major interactions holding the two dimers. Residues participating in binding are shown as ball-and-sticks, color coded by strand color,
except for oxygen (red), nitrogen (blue), and sulfur (yellow).
try (NCS) operator (Figure 2A). The surface area buried 3A). The largely hydrophobic dimer interface is formed
by residues from the C, C, F, and G strands of eachat this interface is about 1000 A˚2, which is significantly
monomer (Figures 3 and 4). CD8 and CTLA-4 are twoless than that buried between monomers. Two NCS-
examples of homodimeric Ig-V dimers (Leahy et al.,related salt bridges between Glu 88 of one dimer and Arg
1992; Ostrov et al., 2000). In the CD8 homodimer, dimer99 of the other are found at this dimer-dimer interface
formation is nearly identical to that of antibody and TCR(Figure 2D).
heterodimers with dimer interface residues conserved
among them. CTLA-4, however, forms a disulfide-
Comparison with Other Ig-V Dimers bonded dimer through a pair of membrane-proximal
It is worth noting that the physiological oligomerization cysteines, and its structure displays a very different type
state of TREM-1 is unknown. This is partly due to the low of dimer formation as that of TCR (Figure 3B). The
cell surface expression of the receptor in nonactivated CTLA-4 dimer interface consists primarily of the A and
myeloid cells and the lack of a stable transfected cell G strands near the C termini of the monomers. As a
line. To address the dimerization of TREM-1, we com- result, the CDR-like loops of the CTLA-4 dimer (BC,
pared the receptor structure with some of the known CC″, and FG loops) are oriented in opposite directions,
Ig-V dimers. The best-studied examples of the V-type generating two separate ligand binding sites. The sur-
Ig fold are structures of the variable domains of antibody face area buried in CTLA-4 homodimer interface is about
Fab fragments and T cell antigen receptors (Harris et 700 A˚2, significantly smaller than that in T cell receptors,
al., 1992; Cohen et al., 1996; Garboczi et al., 1996; Leahy antibodies, and CD8.
et al., 1992; Ostrov et al., 2000). In both antibodies and The most closely related example of a head-to-tail
TCRs, the Ig-V domains form a “head-to-head,” parallel Ig-V dimer is the structure of a nonfunctional V homodi-
heterodimer with the “heads,” CDR loops of each mono- mer (Li et al., 1998) (Figure 3C). However, there are signif-
mer, packing against each other opposite their C-ter- icant structural differences observed between the V
and TREM-1 dimers. In the V homodimer, major interac-minal “tails” that do not pack closely together (Figure
TREM-1 Crystal Structure
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Figure 3. Several Examples of V-Type Domains Forming Homo- and Heterodimers
(A) VHVL of mouse IgG1 (PDB accession code 3HFL). (B) CTLA-4 homodimer (PDB code 1I85). (C) V homodimer (PDB accession code 1TVD).
(D) TREM-1 homodimer. Complementarity determining regions (CDRs) are labeled; BC, CC″ and FG loops correspond to CDR1, CDR2, and
CDR3, respectively. Secondary structure elements involved in dimerization are labeled. Inset: cartoon representation of different dimer formation
modes color coded to match ribbon models.
tions take place between G strands as well as between C strand forms a hydrogen bond to the same Gln residue
from the opposing monomer in most antibody-likeC strands of the opposing monomers. The TREM-1
dimer, however, replaces the interface G strands of the V-type dimers (Figure 4). This Gln residue is changed to
Lys in V and Glu in V that make a salt bridge in theV with a swapped A and A strands (Figure 3D). Since
V forms a nonfunctional dimer in the absence of V, structure of the  TCR. In TREM-1 and V homodimer
isoleucine is found at the same position. The other twowe investigated the possibility that the TREM-1 head-
to-tail dimer may be artificial, due to the absence of the residues that appear to be important in mediating anti-
body-like dimerization are part of the interface hy-70 residue extracellular neck region that is C-terminal
to the Ig-V domain. In the absence of structural informa- drophobic core. One is located in the middle of the C
strand. In antibodies and TCRs, this residue is Leu, Phe,tion regarding the conformation of this neck region, we
used several secondary structure prediction algorithms, and Trp, whereas in CTLA-4 this residue is Glu, which
makes formation of an antibody-like hydrophobic inter-including PSIPRED and SAM to assess the potential fold
of this region (McGuffin et al., 2000; Karplus et al., 1998). face unfavorable. In TREM sequences, either Thr or Gln
is found at this position. The other residue is locatedAll of them predict a lack of a defined fold in the neck
region indicating a potential flexible domain. This sug- in the middle of F strand immediately preceding the
conserved cysteine. It is either a leucine or tyrosine ingests the neck domain is less likely to influence the V
region dimer formation. antibody-like dimers. In TREM sequences, however, this
residue becomes either Gln or Arg, which are less favor-Next, we examined the interface residues of TREM-1
and other V-type IgSF dimers for their compatibility able for a hydrophobic interface. In addition, sequence
comparison between human and mouse TREM-1 re-among different dimerization modes. When the struc-
tures of antibody-like dimers were compared with those veals that residues involved in TREM-1-like dimer forma-
tion are 60% conserved whereas those correspondingof V, CTLA-4, and TREM-1 homodimers, three interface
residues appear to be particularly important in determin- to VHVL-type dimer formation are 40% conserved, sug-
gesting that the antibody-like dimer is less favorableing the mode of dimer formation. A Gln residue, con-
served among antibodies and TCRs, at the end of the than TREM sequences.
Structure
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Figure 4. Structure-Based Sequence Alignment of Several TREMs and Other Members of the Ig-V Superfamily
The numbering is consistent with the mature sequence of human TREM-1. The secondary structure elements of TREM-1 are illustrated as
arrows for  strands and cylinders for  helices. Residues involved in homo- and heterodimer formation are shown on black background.
Cysteins making disulfide bonds conserved for V-type Ig fold are in bold and marked with asterisks. Gaps are indicated with (–). TREM-1
residues violating antibody-like dimer formation mode are marked with closed triangles.
To further evaluate the compatibility of TREM-1 with body-like TREM-1 dimer buries4000 A˚2 interface area,
which is only 100 A˚2 smaller than the value observed foran antibody-like dimer, we superimposed TREM-1 mo-
nomer onto the structure of CD8 (Figure 5A). This anti- the TREM-1 dimer in the crystal structure. However,
Figure 5. Hypothetical Structural Models of TREM-1
(A) TREM-1 structure modeled after CD8 homodimer. C atoms of residues making bad contacts (2.0 A˚) shown as yellow balls.
(B) Cartoon representing TREM-1 dimer with the neck regions bound to the cell membrane. The molecular surface was created using GRASP




there are numerous steric clashes between residues at 3D). This is reminiscent of the structure of CTLA-4/B7-1
(B7-2) complexes in which each CTLA-4 monomer bindsthe dimer interface of this model (Figure 5A). For exam-
ple, both Met 63 and Arg 128 of TREM-1 are in close one B7 molecule and the two ligand binding sites point
away from each other in the CTLA-4 dimer (Figure 3B).contact (2.0 A˚) to main chain atoms of the opposing
monomer. In antibodies and TCRs, both residues are The TREM-1 head-to-tail dimer would also require the
receptor to adopt a different orientation with respectreplaced by much smaller amino acids such as Ser, Gly,
Pro, and Thr to avoid the steric hindrance at the dimer to the membrane compared to head-to-head dimers
(Figure 5B).interface, suggesting that the sequence of TREM-1 is
not compatible with an antibody-like dimer. In summary, the structure of TREM-1 reveals a unique
head-to-tail mode of dimerization different from otherFinally, the TREM-1 dimerization mode was evaluated
using the program SCORE, which calculates the com- known Ig-V domain structures. The dimer interface is
approximately twice the size of antibody-like Ig-V dimerspatibility of a given sequence to adopt a known protein-
protein interaction mode based on the ability of its puta- and involves strand swapping between the first strands
of the monomers. This unique dimer formation likelytive interface residues to form the salt bridges, hydrogen
bonds, and hydrophobic interactions of a known tem- creates two separate ligand binding sites for each
TREM-1 receptor dimer. However, further investiga-plate structure (Radaev et al., 2002). Using this algo-
rithm, we first scored the propensity of V and V se- tions, including the identification of TREM-1 ligands and
the solution of the TREM-1/ligand complex structure,quences of TCR to form the parallel antibody-like
dimer versus the antiparallel V homodimer. When the are needed to gain a better understanding of the function
of TREM-1 and its role in innate immune response.V sequence is scored against either the VV hetero-
dimer or V homodimer crystal structures, the interface
Experimental Procedurescompatibility scores are 26 and 14, respectively. The
higher score obtained for the antibody-like VV hetero-
Protein Expression, Purification, and Crystallization
dimeric structure suggests that V prefers parallel rather The extracellular part of human TREM-1 receptor (residues 17–133
than the antiparallel dimeric structure. Conversely, if of mature sequence) was subcloned into a pET-22b vector using
NdeI and XhoI restriction sites. The recombinant protein was ex-the V sequence is scored against the same structural
pressed in Escherichia coli BL21 (DE3) cells as inclusion bodies andtemplates, the compatibility scores are 7 and 18 for
then reconstituted in vitro. Cells were grown at 37C in 10 liters ofthe VV heterodimeric and V homodimeric structure
Luria-Bertani broth using a New Brunswick Bioflo 3000 Bioreactortemplates, respectively. This is consistent with the crys-
(New Brunswick Scientific Co., Inc., Edison, NJ) vessel and induced
tallographic result that V alone prefers the homodimeric with 0.5 mM IPTG at an approximate OD596 of 1.7 for 4 hr. The
antiparallel structure (Li et al., 1998). When the TREM-1 inclusion bodies were isolated by repeated washing with buffer
containing 2 M urea. Prior to refolding, the inclusion bodies weresequence was evaluated using either the crystal struc-
redissolved in 6 N guanidine hydrochloride, 2 mM DTT, and 50 mMture or the CD8-like model of TREM-1 dimer as the
sodium phosphate at pH 6. The refolding was initiated by a quicktemplate, the scores are 56 and 23 for the antiparallel
dilution of dissolved inclusion bodies into a refolding buffer con-and the parallel dimer, respectively, indicating a prefer-
sisting of 0.5 M L-arginine, 2.5 mM oxidized glutathione, 5 mM
ence of TREM-1 sequence for the antiparallel dimer reduced glutathione, 10 g/ml AEBSF (4-2[-aminoethyl]-ben-
structure. zenesulfonyl fluoride hydrochloride), and 100 mM Tris at pH 8.0 and
then dialyzed thoroughly against water. The renaturated TREM-1
was concentrated on a Ni-NTA affinity column (Qiagen, Inc., Valen-
cia, California) and was further purified on a Superdex 200 size-Potential Ligand Binding Site
exclusion column (Amersham Biosciences, Piscataway, New Jer-Although the ligands of TREM-1 remain to be identified,
sey). Refolded TREM-1 eluted as a dimer on the size-exclusionwe attempted to locate a putative ligand binding site
column with an approximate molecular weight of 30 kDa. The identity
on the receptor based on the known structures of Ig-V of the refolded protein was confirmed by N-terminal amino acid
superfamily members and their modes of ligand binding. sequencing and electrospray ionization mass spectrometry (ESI-
MS). The selenomethionine (SeMet) derivative of TREM-1 was pre-To date, the best-studied structures are those of anti-
pared under altered bacterial growth conditions (Van Duyne et al.,bodies and T cell antigen receptors (Harris et al., 1992;
1993). In brief, bacteria inoculum (40 ml) containing the TREM-1Gao et al., 1997; Stamper et al., 2001; Schwartz et al.,
expression plasmid was grown at 37C in LB broth over night. The2001; Garboczi et al., 1996; Garcia et al., 1996). Other
LB broth in the overnight inoculum was replaced with M9 medium
examples include the two T cell coreceptors CD8, which supplemented with 0.4% glucose, 0.1 mM CaCl2, and 3 mM MgSO4
recognizes the nonpolymorphic 3 domain of MHC mol- and distributed into four 1 liter shaker flasks at 37C. The bacteria
cell culture was induced at an approximate OD596 of 0.6 with 0.5ecules, and CTLA-4, which binds B7-1 and B7-2 (Leahy
mM IPTG for 12 hr together with added 50 mg per liter each of theet al., 1992; Ostrov et al., 2000). Despite their sequence
amino acids Leu, Ile, and Val, and 100 mg per liter each of Thr, Lys,and ligand diversity, antibodies TCRs, CD8, and CTLA-4
Phe, and SeMet. Refolding of the SeMet-modified TREM-1 was theall recognize their cognate ligands using loops that are
same as for the native protein. The presence of four SeMet residues
topologically identical to antibody CDRs. The use of a was confirmed by ESI-MS.
set of common ligand binding regions among otherwise Single crystals were obtained by vapor diffusion in hanging drops
at room temperature using reservoir solutions containing 2.1–2.4 Mdiverse Ig-V domains suggests that these loops are cru-
ammonium sulfate and 100 mM MES or sodium citrate at pH 5.4–5.7.cial for ligand recognition by members of this superfam-
Crystals appeared after 1–3 days and grew to an average size ofily. Thus, it is conceivable that TREM-1 also captures its
0.1 	 0.04 	 0.02 mm in approximately 2 weeks. Crystals grownligand with its CDR-equivalent loop regions. The unique
using sodium citrate buffer were typically larger and had the same
dimer structure of TREM-1, however, predicts two sepa- morphology as those grown using MES, but displayed nonisotropic
rate ligand binding sites as compared to antibodies TCR and streaking diffraction only to 3.5 A˚ upon freezing. As a result,
only those crystals obtained in MES buffer were used for structureand CD8 which contain only one binding site (Figure
Structure
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solution. Following brief soaking in a solution containing 1.8 M am- J. (2003). The human TREM gene cluster at 6p21.1 encodes both
activating and inhibitory single IgV domain receptors and includesmonium sulfate, 100 mM Li2SO4, 100 mM MES, pH 5.7, and 20%
glycerol, crystals were flash frozen in a liquid nitrogen stream. NKp44. Eur. J. Immunol. 33, 567–577.
ESI-MS was utilized to facilitate the search for possible heavy-metal Bennett, M.J., Schlunegger, M.P., and Eisenberg, D. (1995). 3D do-
derivatives (Sun and Hammer, 2000). Heavy-metal solutions were main swapping: a mechanism for oligomer assembly. Protein Sci.
mixed with the protein in crystallization buffer, incubated for 30 min 4, 2455–2468.
to several hours, and analyzed by mass spectrometry.
Beutler, B., Milsark, I.W., and Cerami, A.C. (1985). Passive immuniza-
tion against cachectin/tumor necrosis factor protects mice from
Structure Determination
lethal effect of endotoxin. Science 229, 869–871.
Multiwavelength anomalous diffraction (MAD) data sets from SeMet
Bleharski, J.R., Kiessler, V., Buonsanti, C., Sieling, P.A., Stenger, S.,TREM-1 crystal and from native TREM-1 crystal quick soaked for
Colonna, M., and Modlin, R.L. (2003). A role for triggering receptor10 min in saturated solution of KAu(CN)2 (Sun et al., 2002; Sun and
expressed on myeloid cells-1 in host defense during the early-inducedRadaev, 2002) were collected at Southeast Regional Collaborative
and adaptive phases of the immune response. J. Immunol. 170,Access Team (SER-CAT) 22-ID beamline at the Advanced Photon
3812–3818.Source, Argonne National Laboratory. The native data set was col-
lected at SBC-CAT beamline. Supporting institutions are listed at Bouchon, A., Dietrich, J., and Colonna, M. (2000). Cutting edge:
www.ser.anl.gov/new/members.html. The data were processed and inflammatory responses can be triggered by TREM-1, a novel recep-
scaled with HKL2000 (Otwinowski and Minor, 1997). The crystals tor expressed on neutrophils and monocytes. J. Immunol. 164, 4991–
belong to the monoclinic space group P21 with cell dimensions a  4995.
50.3, b  128.6, c  62.4 A˚, and   101.7 and contain four mole- Bouchon, A., Facchetti, F., Weigand, M.A., and Colonna, M. (2001).
cules per asymmetric unit. Ten out of sixteen Se sites were located TREM-1 amplifies inflammation and is a crucial mediator of septic
by the program SOLVE (Terwilliger and Berendzen, 1999) using dif- shock. Nature 410, 1103–1107.
fraction data from 15–4 A˚. Consecutive density modification with
Brunger, A.T., Adams, P.D., Clore, G.M., DeLano, W.L., Gros, P.,2-fold NCS averaging and phase extension to 2.8 A˚ with the program
Grosse-Kunstleve, R.W., Jiang, J.-S., Kuszewski, J., Nilges, N.,DM (Cowtan and Main, 1996) followed by solvent flipping by SOLO-
Pannu, N.S., et al. (1998). Crystallography & NMR system (CNS): aMON (Abrahams and Leslie, 1996) from CCP4 program suite (CCP4,
new software system for macromolecular structure determination.1994) resulted in an electron density map that showed recognizable
Acta Crystallogr. D 54, 905–921.secondary structure elements but remained difficult to trace. Phases
Cantoni, C., Ponassi, M., Biassoni, R., Conte, R., Spallarossa, A.,calculated from this electron density map were used to locate a
Moretta, A., Moretta, L., Bolognesi, M., and Bordo, D. (2003). Thesingle heavy-metal site in a difference Fourier map calculated be-
three-dimensional structure of the human NK cell receptor NKp44,tween the KAu(CN)2 derivative (remote wavelength) and the native
a triggering partner in natural cytotoxicity. Structure 11, 725–734.dataset. MIR phases were then calculated using the remote wave-
length of KAu(CN)2 and the peak wavelength of the SeMet derivatives CCP4 (Collaborative Computational Project) (1994). The CCP4 suite:
with MLPHARE (CCP4, 1994), and subsequently combined with the programs for protein crystallography. Acta Crystallogr. D 50,
MAD phases of the SeMet derivative from SOLVE. Density modifica- 760–763.
tion including NCS averaging, solvent flipping, and incremental Chothia, C. (1975). Structural invariants in protein folding. Nature
phase extension to 2.8 A˚ resulted in an improved and interpretable 254, 304–308.
electron density map. The program “O” was used for model building
Chung, D.H., Seaman, W.E., and Daws, M.R. (2002). Characterizationand adjustment (Kleywegt and Jones, 1997). Positional and individ-
of TREM-3, an activating receptor on mouse macrophages: defini-ual B factor refinement of the native dataset was carried out using
tion of a family of single Ig domain receptors on mouse chromosomethe maximum likelihood target function of CNS v1.0 (Brunger et al.,
17. Eur. J. Immunol. 32, 59–66.1998). Due to the high ammonium sulfate content (2.1–2.4 M) in the
Cohen, J. (2001). TREM-1 in sepsis. Lancet 358, 776–778.crystallization buffer, ten sulfate ions were built into densities near
positively charged arginine and lysine residues. In addition, a well- Cohen, G.H., Sheriff, S., and Davies, D. (1996). Refined structure of
defined glutathione molecule was built into one of the four TREM the monoclonal antibody HyHEL-5 with its antigen hen egg-white
monomers in the asymmetric unit, forming a disulfide bond to Cys lysozyme. Acta Crystallogr. D 52, 315–326.
69. Surface areas were calculated with the program SURFACE as Cowtan, K., and Main, P. (1996). Phase combination and cross vali-
part of the CCP4 program suite using a probe radius of 1.4 A˚ dation in iterated density-modification calculations. Acta Crys-
(Chothia, 1975). tallogr. D 52, 43–48.
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